Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Actinium Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$1.9

2024-10-29

Market Capitalization

$58.6 M

2024-10-29

Revenue

$90 K

FY, 2025

CreditSafe Score

?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue1.1M1.0M81.0K90.0K
Cost of goods sold900.0K
General and administrative expense337.04.5M3.9M10.2M11.5M9.3M9.2M6.7M5.5M6.3M8.1M12.0M13.3M12.1M
Operating expense total10.0K7.9M6.6M22.4M24.8M26.8M26.9M23.8M22.1M22.4M25.2M35.1M52.0M42.1M
Depreciation and amortization1.6K53.5K77.5K55.9K
EBIT(10.0K)(7.9M)(6.6M)(22.5M)(24.8M)(26.8M)(26.9M)(23.8M)(22.1M)(22.4M)(25.0M)(34.1M)(51.9M)(42.1M)
EBIT margin, %-3311.1%-64098.8%
Investment income5.4K
Interest income3.9M
Interest expense4.8K1.1M4.2M866.03.8M2.5M309.6K173.4K172.4K178.0K190.0K1.1M3.1M
Pre tax profit(33.3M)
Net Income10.3K(8.4M)(10.8M)(24.7M)(21.0M)(24.3M)(26.6M)(23.7M)(21.9M)(22.2M)(24.8M)(33.0M)(48.8M)(38.2M)
EPS(1.4)(1.8)(1.3)(1.1)

Footer menu